129 related articles for article (PubMed ID: 37745050)
1. Exploration of potential novel drug targets and biomarkers for small cell lung cancer by plasma proteome screening.
Wu Y; Wang Z; Yang Y; Han C; Wang L; Kang K; Zhao A
Front Pharmacol; 2023; 14():1266782. PubMed ID: 37745050
[No Abstract] [Full Text] [Related]
2. Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis.
Lin J; Zhou J; Xu Y
Brain; 2023 Aug; 146(8):3364-3372. PubMed ID: 36864689
[TBL] [Abstract][Full Text] [Related]
3. Exploration of potential novel drug targets for diabetic retinopathy by plasma proteome screening.
Yuan W; Xu W; Xu X; Qu B; Zhao F
Sci Rep; 2024 May; 14(1):11726. PubMed ID: 38778174
[TBL] [Abstract][Full Text] [Related]
4. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.
Zhang L; Xiong Y; Zhang J; Feng Y; Xu A
J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019
[TBL] [Abstract][Full Text] [Related]
5. Promising therapeutic targets for ischemic stroke identified from plasma and cerebrospinal fluid proteomes: a multicenter Mendelian randomization study.
Zou X; Wang L; Wang S; Zhang Y; Ma J; Chen L; Li Y; Yao TX; Zhou H; Wu L; Tang Q; Ma S; Zhang X; Tang R; Yi Y; Liu R; Zeng Y; Zhang L
Int J Surg; 2024 Feb; 110(2):766-776. PubMed ID: 38016292
[TBL] [Abstract][Full Text] [Related]
6. Potential drug targets for tumors identified through Mendelian randomization analysis.
Song N; Shi P; Cui K; Zeng L; Wang Z; Di W; Li J; Fan Y; Li Z; Zhang J; Su W; Wang H
Sci Rep; 2024 May; 14(1):11370. PubMed ID: 38762700
[TBL] [Abstract][Full Text] [Related]
7. Uncovering novel drug targets for bipolar disorder: a Mendelian randomization analysis of brain, cerebrospinal fluid, and plasma proteomes.
Jia T; Liu T; Hu S; Li Y; Chen P; Qin F; He Y; Han F; Zhang C
Psychol Med; 2024 May; ():1-11. PubMed ID: 38720515
[TBL] [Abstract][Full Text] [Related]
8. Proteome-Wide Multicenter Mendelian Randomization Analysis to Identify Novel Therapeutic Targets for Lung Cancer.
Wang K; Yi H; Wang Y; Jin D; Zhang G; Mao Y
Arch Bronconeumol; 2024 May; ():. PubMed ID: 38824092
[TBL] [Abstract][Full Text] [Related]
9. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
Yang C; Fagan AM; Perrin RJ; Rhinn H; Harari O; Cruchaga C
Genome Med; 2022 Dec; 14(1):140. PubMed ID: 36510323
[TBL] [Abstract][Full Text] [Related]
10. Novel Drug Targets for Ischemic Stroke Identified Through Mendelian Randomization Analysis of the Blood Proteome.
Chong M; Sjaarda J; Pigeyre M; Mohammadi-Shemirani P; Lali R; Shoamanesh A; Gerstein HC; Paré G
Circulation; 2019 Sep; 140(10):819-830. PubMed ID: 31208196
[TBL] [Abstract][Full Text] [Related]
11. An Integrative Genomic Strategy Identifies sRAGE as a Causal and Protective Biomarker of Lung Function.
Keefe J; Yao C; Hwang SJ; Courchesne P; Lee GY; Dupuis J; Mizgerd JP; O'Connor G; Washko GR; Cho MH; Silverman EK; Levy D
Chest; 2022 Jan; 161(1):76-84. PubMed ID: 34237330
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome.
Sun J; Zhao J; Jiang F; Wang L; Xiao Q; Han F; Chen J; Yuan S; Wei J; Larsson SC; Zhang H; Dunlop MG; Farrington SM; Ding K; Theodoratou E; Li X
Genome Med; 2023 Sep; 15(1):75. PubMed ID: 37726845
[TBL] [Abstract][Full Text] [Related]
13. Proteome-wide Mendelian randomization identifies causal plasma proteins in lung cancer.
Li H; Du S; Dai J; Jiang Y; Li Z; Fan Q; Zhang Y; You D; Zhang R; Zhao Y; Christiani DC; Shen S; Chen F
iScience; 2024 Feb; 27(2):108985. PubMed ID: 38333712
[TBL] [Abstract][Full Text] [Related]
14. Proteome-wide mendelian randomization study implicates therapeutic targets in common cancers.
Ren F; Jin Q; Liu T; Ren X; Zhan Y
J Transl Med; 2023 Sep; 21(1):646. PubMed ID: 37735436
[TBL] [Abstract][Full Text] [Related]
15. Potential drug targets for asthma identified in the plasma and brain through Mendelian randomization analysis.
Wang Y; Wang J; Yan Z; Liu S; Xu W
Front Immunol; 2023; 14():1240517. PubMed ID: 37809092
[TBL] [Abstract][Full Text] [Related]
16. Investigating Causal Associations of Circulating Micronutrients Concentrations with the Risk of Lung Cancer: A Mendelian Randomization Study.
Yan H; Jin X; Yin L; Zhu C; Feng G
Nutrients; 2022 Oct; 14(21):. PubMed ID: 36364831
[TBL] [Abstract][Full Text] [Related]
17. Novel Causal Plasma Proteins for Hypothyroidism: A Large-scale Plasma Proteome Mendelian Randomization Analysis.
Yang H; Chen L; Liu Y
J Clin Endocrinol Metab; 2023 Jan; 108(2):433-442. PubMed ID: 36190832
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential drug targets for varicose veins: a Mendelian randomization analysis.
Lin J; Zhou J; Liu Z; Zeng R; Wang L; Li F; Cui L; Zheng Y
Front Cardiovasc Med; 2023; 10():1126208. PubMed ID: 37404740
[TBL] [Abstract][Full Text] [Related]
19. Genetic evidence for a causal relationship between type 2 diabetes and peripheral artery disease in both Europeans and East Asians.
Xiu X; Zhang H; Xue A; Cooper DN; Yan L; Yang Y; Yang Y; Zhao H
BMC Med; 2022 Aug; 20(1):300. PubMed ID: 36042491
[TBL] [Abstract][Full Text] [Related]
20. Identifying therapeutic targets for breast cancer: insights from systematic Mendelian randomization analysis.
Yao T; Lin YL; Wu YQ; Qian XG; Wang ZN; Qian S; Jiang T; Liu JC; Fang LX; Zhen C; Wu CH
Front Oncol; 2024; 14():1407795. PubMed ID: 38887235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
